NASDAQ:GLUE | Income Statement | Monte Rosa Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$8.97M$47.96M$58.1M-$49.13M$5.94M-$43.19M$208,000.00-$43.4M101,478,945101,478,945
2026-03-31$4.21M$44.07M$54.24M-$50.03M$5.58M-$44.45M$52,000.00-$44.5M99,883,87899,883,878
2025-12-31$2.78M$41.98M$52.5M-$49.72M$3.64M-$46.08M$59,000.00-$46.14M825,861128,462
2025-09-30$12.77M$36.68M$45.74M-$32.98M$2.72M-$30.26M-$3.18M-$27.08M82,397,75382,397,753
2025-06-30$23.19M$30.65M$38.75M-$15.55M$4.46M-$11.1M$1.2M-$12.3M82,186,76882,186,768
2025-03-31$84.93M$32.19M$40.89M$44.04M$3.67M$47.71M$822,000.00$46.89M82,148,71982,956,423
2024-12-31$60.65M$38.87M$47.64M$13M$2.6M$15.6M$2.16M$13.44M2,736,3792,736,379
2024-09-30$9.22M$27.62M$35.74M-$26.53M$2.74M-$23.79M$71,000.00-$23.86M82,011,67082,011,670
2024-06-30$4.7M$28.06M$37.34M-$32.64M$2.58M-$30.06M$252,000.00-$30.31M71,233,99271,233,992
2024-03-31$1.06M$27.03M$36.01M-$34.95M$3.06M-$31.89M$83,000.00-$31.97M60,156,18760,156,187
2023-12-31$0.00$27.14M$34.86M-$34.86M$1.59M-$33.27M-$22,000.00-$33.25M1,863,8181,863,818
2023-09-30$0.00$28.31M$36.97M-$36.97M$2.25M-$34.71M$170,000.00-$34.88M49,814,90349,814,903
2023-06-30$0.00$29.08M$37.22M-$37.22M$2.23M-$34.99M$190,000.00-$35.18M49,431,92249,431,922
2023-03-31$0.00$26.76M$34.26M-$34.26M$2.22M-$32.04M$0.00-$32.04M49,347,47349,347,473
2022-12-31$24.87M$32.49M-$32.49M$1.71M-$30.78M$0.00-$30.78M561,370561,370
2022-09-30$21.34M$28.36M-$28.36M$1.04M-$27.32M$0.00-$27.32M46,732,35346,732,353
2022-06-30$20.94M$27.23M-$27.23M$762,000.00-$26.47M$0.00-$26.47M46,668,36946,668,369
2022-03-31$17.92M$24.3M-$24.3M$370,000.00$0.00-$23.93M46,595,78246,595,782
2021-12-31$18.13M$23.39M-$23.39M-$53,000.00-$23.44M7,248,7147,248,714
2021-09-30$15.12M$19.87M-$19.87M$31,000.00-$19.84M45,987,86645,987,866
2021-06-30$14.64M$18.12M-$18.12M-$282,000.00-$18.41M5,070,5545,070,554
2021-03-31$9.27M$11.5M-$11.5M-$772,000.00$0.00-$12.28M1,709,227
2020-12-31$9.86M$11.94M-$11.94M-$7.72M-$19.66M42,867
2020-09-30$5.47M$6.39M-$6.39M-$172,000.00-$6.56M1,529,881
2020-06-30$4.86M$5.4M-$5.4M$32,000.00-$5.36M1,475,409
2020-03-31-$4.3M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$123.67M$141.5M$177.88M-$54.21M$14.49M-$39.72M-$1.1M-$38.63M83,071,18583,071,185
2024-12-31$75.62M$121.56M$156.73M-$81.11M$10.98M-$70.13M$2.57M-$72.7M73,910,02673,910,026
2023-12-31$0.00$111.27M$143.31M-$143.31M$8.3M-$135.01M$338,000.00-$135.35M51,396,96151,396,961
2022-12-31$85.06M$112.38M-$112.38M$3.88M-$108.5M$0.00-$108.5M47,227,37047,227,370
2021-12-31$57.16M$72.88M-$72.88M-$1.08M-$73.96M25,000,12425,000,124
2020-12-31$24.01M$28.01M-$28.01M-$7.87M-$35.88M1,516,912